Cigna modified MM 0057 covering mammary ductoscopy, ductal lavage, and mammary duct aspiration, effective January 16, 2026. Every claim your team submits under CPT 19499 for these procedures will be denied.
Cigna Healthcare classifies all three procedures — mammary ductoscopy, ductal lavage of the mammary ducts, and mammary duct aspiration using a non-invasive device — as experimental, investigational, and unproven. The only applicable billing code is CPT 19499 (unlisted procedure, breast), and Cigna's coverage policy under MM 0057 in the Cigna system makes clear: that code gets no reimbursement for these indications. If your practice or billing team handles breast imaging, surgical oncology, or preventive breast care for Cigna members, this policy directly affects your revenue.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Mammary Ductoscopy, Aspiration and Lavage — MM 0057 |
| Policy Code | MM 0057 |
| Change Type | Modified |
| Effective Date | January 16, 2026 |
| Impact Level | High — all claims for these procedures are non-covered |
| Specialties Affected | Breast surgery, surgical oncology, gynecologic oncology, breast radiology |
| Key Action | Stop billing CPT 19499 for mammary ductoscopy, ductal lavage, or duct aspiration against Cigna — update charge capture and inform patients of non-coverage before January 16, 2026 |
Cigna Mammary Ductoscopy Coverage Criteria and Medical Necessity Requirements 2026
The Cigna mammary ductoscopy coverage policy under MM 0057 does not establish a path to coverage. There are no medical necessity criteria that unlock reimbursement. Cigna's position is categorical: these procedures do not meet the standard for coverage under any clinical circumstance.
That means there is no medical necessity checklist to satisfy, no prior authorization pathway to pursue, and no combination of diagnosis codes that makes a claim payable. The procedures covered by this policy are mammary ductoscopy (direct visualization of the mammary ducts), ductal lavage (fluid collection from mammary ducts for cytologic analysis), and non-invasive mammary duct aspiration. All three are used in the screening and early detection of breast cancer — but Cigna does not accept that clinical application as a basis for reimbursement.
The real issue here is that some practices continue to bill CPT 19499 for these procedures hoping for inconsistent adjudication results. That approach creates claim denial exposure and, depending on how the services are presented to patients, potential compliance problems. If you're offering these procedures to Cigna members, your financial counseling process needs to address self-pay expectations before the patient hits the table.
Prior authorization is not mentioned in this policy because prior auth is irrelevant when there is no coverage. Requesting prior auth for a non-covered service does not create a payment obligation for the payer — and getting a prior auth reference number on a non-covered service can create patient expectation problems your billing team will spend months unwinding.
Cigna Mammary Ductoscopy Exclusions and Non-Covered Indications
Cigna's coverage policy under MM 0057 applies the experimental, investigational, and unproven designation to all uses of these procedures. The clinical context — breast cancer screening, early detection, atypical ductal hyperplasia evaluation — does not change that classification.
Three specific procedures fall under this exclusion:
Mammary ductoscopy — direct endoscopic examination of the breast ductal system.
Ductal lavage of the mammary ducts — infusion and collection of fluid from ducts for cytologic evaluation.
Mammary duct aspiration using a non-invasive device — collection of nipple aspirate fluid without surgical access.
Cigna's position is that the evidence does not support these procedures as clinically effective screening or early detection tools. That may frustrate providers who use ductal lavage or ductoscopy for high-risk patients. But the coverage policy doesn't move for clinical preference — it moves for evidence, and Cigna has not updated its evidence threshold here.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Mammary ductoscopy for breast cancer screening or early detection | Not Covered — Experimental/Investigational/Unproven | CPT 19499 | No prior auth pathway; patient must be informed of non-coverage |
| Ductal lavage of mammary ducts | Not Covered — Experimental/Investigational/Unproven | CPT 19499 | Non-covered regardless of clinical indication |
| Mammary duct aspiration via non-invasive device | Not Covered — Experimental/Investigational/Unproven | CPT 19499 | Applies to all Cigna members; self-pay consent recommended |
Cigna Mammary Ductoscopy Billing Guidelines and Action Items 2026
The mammary ductoscopy billing situation under MM 0057 is straightforward — but the operational steps still require attention before January 16, 2026.
| # | Action Item |
|---|---|
| 1 | Pull your CPT 19499 claim history for Cigna now. Identify any claims billed for mammary ductoscopy, ductal lavage, or duct aspiration in the past 12 months. If any were paid, review how they were coded and whether they're subject to retrospective audit or recoupment. Talk to your compliance officer before the effective date if you find paid claims under this code for these procedures. |
| 2 | Update your charge capture to flag CPT 19499 for these indications. Your billing system should prevent CPT 19499 from routing toward Cigna payers when the associated diagnosis or procedure note indicates ductoscopy, ductal lavage, or duct aspiration. This is a coding workflow change, not just a policy awareness issue. |
| 3 | Update your ABN and financial consent process for Cigna patients. Since these procedures are non-covered, not just subject to prior auth requirements, patients need to understand before service that Cigna will not pay. Document that conversation. This protects your practice and sets accurate financial expectations. |
| 4 | Do not pursue prior authorization for these procedures under Cigna. Getting a PA reference number on a non-covered service does not create liability for Cigna. It creates patient confusion. Your front-desk and scheduling teams need to know this — not just your billers. |
| 5 | Audit any scheduled procedures for Cigna members through Q1 2026. If patients are scheduled for mammary ductoscopy or ductal lavage and carry Cigna coverage, contact them before their appointment. Have the financial counseling conversation before the service date, not after the claim denial. |
| 6 | If your practice has an existing policy or fee schedule for these procedures, review it for Cigna carve-outs. Some practices maintain in-house rates for procedures that are non-covered by most commercial payers. Make sure those rates are documented and disclosed properly for Cigna members. |
If you're not sure how this applies to your patient mix or whether retrospective claims create compliance exposure, loop in your compliance officer before January 16, 2026.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Mammary Ductoscopy Under MM 0057
The Cigna MM 0057 policy lists one applicable code. There are no covered CPT codes under this policy — only a non-covered designation.
Not Covered / Experimental Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 19499 | CPT | Unlisted procedure, breast | Considered Experimental/Investigational/Unproven when used for mammary ductoscopy, ductal lavage, or mammary duct aspiration |
No HCPCS codes are listed in this policy.
No ICD-10-CM diagnosis codes are listed in this policy.
The absence of ICD-10 codes is notable. It means Cigna is not tying this non-covered designation to specific diagnoses — it applies to the procedure itself, regardless of the clinical context or the patient's risk profile. A high-risk patient with BRCA mutation and a history of atypical ductal hyperplasia gets the same non-covered result as any other Cigna member. The diagnosis does not unlock coverage here.
One practical note on CPT 19499: because it's an unlisted code, it already triggers manual review in most billing workflows. Your team may have built workarounds to get unlisted breast procedures through adjudication. Those workarounds do not change the coverage policy, and they don't protect you from recoupment if a paid claim is later reviewed against MM 0057.
Get the Full Picture for CPT 19499
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.